Adenine nucleotide translocase 2 is a key mitochondrial protein in cancer metabolism
- 30 June 2011
- journal article
- review article
- Published by Elsevier BV in Biochimica et Biophysica Acta (BBA) - Bioenergetics
- Vol. 1807 (6), 562-567
- https://doi.org/10.1016/j.bbabio.2010.10.008
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- The MeCP2/YY1 interaction regulates ANT1 expression at 4q35: novel hints for Rett syndrome pathogenesisHuman Molecular Genetics, 2010
- Metabolic genes in cancer: Their roles in tumor progression and clinical implicationsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2010
- The mitochondrial permeability transition from yeast to mammalsFEBS Letters, 2010
- Oligomycin-induced Bioenergetic Adaptation in Cancer Cells with Heterogeneous Bioenergetic OrganizationPublished by Elsevier BV ,2010
- Forward operation of adenine nucleotide translocase during F0F1‐ATPase reversal: critical role of matrix substrate‐level phosphorylationThe FASEB Journal, 2010
- Mitochondrial Energetics and TherapeuticsAnnual Review Of Pathology-Mechanisms Of Disease, 2010
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- Suppression of adenine nucleotide translocase-2 by vector-based siRNA in human breast cancer cells induces apoptosis and inhibits tumor growth in vitro and in vivoBreast Cancer Research, 2008
- A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary MedicineAnnual Review of Genetics, 2005
- The ADP/ATP translocator is not essential for the mitochondrial permeability transition poreNature, 2004